Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 2/2011

Open Access 01-08-2011 | Gynecologic Oncology

Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT

Authors: Michael von Wolff, Markus Montag, Ralf Dittrich, Dominik Denschlag, Frank Nawroth, Barbara Lawrenz

Published in: Archives of Gynecology and Obstetrics | Issue 2/2011

Login to get access

Abstract

Purpose

Fertility preservation methods are playing an increasing role in women up to the age of 40 years because of rising survival rates in those affected by cancer. However, balanced practical recommendations concerning all relevant fertility preservation, to support doctors in counselling and treating patients, are still rare.

Methods

These recommendations were prepared by the network FertiPROTEKT (http://​www.​fertiprotect.​eu), a collaboration of around 70 centres in Germany, Switzerland and Austria. The recommendations were developed by specialists in reproductive medicine, reproductive biology and oncology, which gave a comprehensive overview of all named techniques as well as their benefits and risks. Furthermore, practice-orientated recommendations for the individual use of fertility preservation methods for various indications such as breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours are given.

Results

Various options such as ovarian stimulation and cryopreservation of unfertilised or fertilised oocytes, cryopreservation and transplantation of ovarian tissue, GnRH-agonist administration and transposition of the ovaries can be offered. All the techniques can be performed alone or in combination within a maximum of 2 weeks with low risk and different success rates.

Conclusions

Fertility preservation in women has become an option with realistic chances to become pregnant after cytotoxic therapies. The information provided allows a well balanced and realistic counselling and treatment.
Literature
1.
go back to reference Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRef Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRef
2.
go back to reference Jeruss JS, Woodruff TK (2009) Preservation of fertility in patients with cancer. N Engl J Med 360:902–911PubMedCrossRef Jeruss JS, Woodruff TK (2009) Preservation of fertility in patients with cancer. N Engl J Med 360:902–911PubMedCrossRef
3.
go back to reference FertiPROTEKT. Website of the “Network for fertility preservation before chemo and radiotherapy”, http://www.fertiprotekt.eu. Responsible: Prof. Dr. Michael von Wolff. Installed 01’ 2007, Last update 03’ 2009 FertiPROTEKT. Website of the “Network for fertility preservation before chemo and radiotherapy”, http://​www.​fertiprotekt.​eu. Responsible: Prof. Dr. Michael von Wolff. Installed 01’ 2007, Last update 03’ 2009
4.
go back to reference Al-Inany HG, Abou-Setta AM, Aboulghar M (2007) Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 14:640–649PubMedCrossRef Al-Inany HG, Abou-Setta AM, Aboulghar M (2007) Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 14:640–649PubMedCrossRef
5.
go back to reference von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92:1360–1365CrossRef von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92:1360–1365CrossRef
6.
go back to reference Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O (2009) Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 91:365–371PubMedCrossRef Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O (2009) Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 91:365–371PubMedCrossRef
7.
go back to reference Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885–3890PubMedCrossRef Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885–3890PubMedCrossRef
8.
go back to reference Barritt J, Luna M, Duke M, Grunfeld L, Mukheerje T, Sandler B, Copperman AB (2007) Report of four donor-recipient oocyte Cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil Steril 87:189e13–189e17CrossRef Barritt J, Luna M, Duke M, Grunfeld L, Mukheerje T, Sandler B, Copperman AB (2007) Report of four donor-recipient oocyte Cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil Steril 87:189e13–189e17CrossRef
9.
go back to reference Cobo A, Bellver J, Domingo J, Pérez S, Crespo J, Pellicer A, Remohi J (2008) New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. RBM Online 17:68–72PubMed Cobo A, Bellver J, Domingo J, Pérez S, Crespo J, Pellicer A, Remohi J (2008) New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. RBM Online 17:68–72PubMed
10.
go back to reference Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M (2010) Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases. Fertil Steril (Epub ahead of print) Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M (2010) Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases. Fertil Steril (Epub ahead of print)
11.
go back to reference Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M (2011) Fertility preservation in >1000 patients—patients characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet (in press) Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M (2011) Fertility preservation in >1000 patients—patients characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet (in press)
12.
go back to reference Montag M, Tolba R, Schulz M, Sadek F, van der Ven H (2007) Untersuchungen zum Einfluss des Mediums auf den Transport von Ovarialgewebe im Rahmen der Fertilitätsprotektion. J Reprod Endokrinol 5:264 Montag M, Tolba R, Schulz M, Sadek F, van der Ven H (2007) Untersuchungen zum Einfluss des Mediums auf den Transport von Ovarialgewebe im Rahmen der Fertilitätsprotektion. J Reprod Endokrinol 5:264
13.
go back to reference Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E (2008) Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 23:2266–2272PubMedCrossRef Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E (2008) Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 23:2266–2272PubMedCrossRef
14.
go back to reference Isachenko V, Isachenko E, Weiss JM, Todorov P, Kreienberg R (2009) Cryobanking of human ovarian tissue for anti-cancer treatment: comparison of vitrification and conventional freezing. Cryo Lett 30:449–454 Isachenko V, Isachenko E, Weiss JM, Todorov P, Kreienberg R (2009) Cryobanking of human ovarian tissue for anti-cancer treatment: comparison of vitrification and conventional freezing. Cryo Lett 30:449–454
15.
go back to reference von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY (2009) Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy—a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547–1553CrossRef von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY (2009) Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy—a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547–1553CrossRef
16.
go back to reference Schmidt KT, Rosendahl M, Ernst E, Loft A, Andersen AN, Dueholm M, Ottosen C, Andersen CY (2010) Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience. Fertil Steril (Epub ahead of print) Schmidt KT, Rosendahl M, Ernst E, Loft A, Andersen AN, Dueholm M, Ottosen C, Andersen CY (2010) Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience. Fertil Steril (Epub ahead of print)
17.
go back to reference Bittinger SE, Nazaretian SP, Gook DA, Parmar C, Harrup RA, Stern CJ (2010) Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril (Epub ahead of print) Bittinger SE, Nazaretian SP, Gook DA, Parmar C, Harrup RA, Stern CJ (2010) Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril (Epub ahead of print)
18.
go back to reference Sánchez-Serrano M, Novella-Maestre E, Roselló-Sastre E, Camarasa N, Teruel J, Pellicer A (2009) Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod 24:2238–2243PubMedCrossRef Sánchez-Serrano M, Novella-Maestre E, Roselló-Sastre E, Camarasa N, Teruel J, Pellicer A (2009) Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod 24:2238–2243PubMedCrossRef
19.
go back to reference Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Ben Yehuda D (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23:1007–1013PubMedCrossRef Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Ben Yehuda D (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23:1007–1013PubMedCrossRef
20.
go back to reference Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543–552PubMedCrossRef Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543–552PubMedCrossRef
21.
go back to reference von Wolff M, Kämmerer U, Kollmann Z, Santi A, Dietl J, Frambach T (2010) Combination of gonadotropin-releasing hormone (GnRH) agonists with GnRH antagonists before chemotherapy reduce but do not completely prevent a follicle-stimulating hormone flare-up. Fertil Steril (in press) von Wolff M, Kämmerer U, Kollmann Z, Santi A, Dietl J, Frambach T (2010) Combination of gonadotropin-releasing hormone (GnRH) agonists with GnRH antagonists before chemotherapy reduce but do not completely prevent a follicle-stimulating hormone flare-up. Fertil Steril (in press)
22.
go back to reference Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561PubMedCrossRef Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561PubMedCrossRef
23.
go back to reference Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA (2009) Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 18(3):311–319CrossRef Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA (2009) Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 18(3):311–319CrossRef
24.
go back to reference Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM (2010) Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 122:803–811PubMedCrossRef Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM (2010) Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 122:803–811PubMedCrossRef
25.
go back to reference Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, Al-Inany HG, Falcone T (2010) Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril 95:906–914PubMedCrossRef Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, Al-Inany HG, Falcone T (2010) Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril 95:906–914PubMedCrossRef
26.
go back to reference Olive DL (2008) Gonadotropin-releasing hormone agonists for endometriosis. N Engl J Med 359:1136–1142PubMedCrossRef Olive DL (2008) Gonadotropin-releasing hormone agonists for endometriosis. N Engl J Med 359:1136–1142PubMedCrossRef
27.
go back to reference Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M (2010) Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently and safely combined. Fertil Steril (Epub ahead of print) Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M (2010) Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently and safely combined. Fertil Steril (Epub ahead of print)
28.
go back to reference Maman E, Prokopis K, Levron J, Carmely A, Dor J, Meirow D (2009) Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study. Hum Reprod 24:206–210PubMedCrossRef Maman E, Prokopis K, Levron J, Carmely A, Dor J, Meirow D (2009) Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study. Hum Reprod 24:206–210PubMedCrossRef
29.
go back to reference Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18:117–121PubMedCrossRef Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18:117–121PubMedCrossRef
30.
go back to reference Wo JY, Viswanathan AN (2009) Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73:1304–1312PubMedCrossRef Wo JY, Viswanathan AN (2009) Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73:1304–1312PubMedCrossRef
31.
go back to reference Bisharah M, Tulandi T (2003) Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 188:367–370PubMedCrossRef Bisharah M, Tulandi T (2003) Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 188:367–370PubMedCrossRef
32.
go back to reference Bloemers MC, Portelance L, Legler C, Renaud MC, Tan SL (2010) Preservation of ovarian function by ovarian transposition prior to concurrent chemotherapy and pelvic radiation for cervical cancer. A case report and review of the literature. Eur J Gynaecol Oncol 31:194–197PubMed Bloemers MC, Portelance L, Legler C, Renaud MC, Tan SL (2010) Preservation of ovarian function by ovarian transposition prior to concurrent chemotherapy and pelvic radiation for cervical cancer. A case report and review of the literature. Eur J Gynaecol Oncol 31:194–197PubMed
33.
go back to reference Anderson B, LaPolla J, Turner D, Chapman G, Buller R (1993) Ovarian transposition in cervical cancer. Gynecol Oncol 49:206–214PubMedCrossRef Anderson B, LaPolla J, Turner D, Chapman G, Buller R (1993) Ovarian transposition in cervical cancer. Gynecol Oncol 49:206–214PubMedCrossRef
34.
go back to reference Sankila R, Heinävaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823PubMed Sankila R, Heinävaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823PubMed
35.
go back to reference Azim AA, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26:2630–2635PubMedCrossRef Azim AA, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26:2630–2635PubMedCrossRef
37.
go back to reference Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, Rodolakis A (2010) Fertility preservation in borderline ovarian neoplasm (tumor of low malignant potential): ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest 70:160–165PubMedCrossRef Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, Rodolakis A (2010) Fertility preservation in borderline ovarian neoplasm (tumor of low malignant potential): ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest 70:160–165PubMedCrossRef
38.
go back to reference Fain-Kahn V, Poirot C, Uzan C, Prades M, Gouy S, Genestie C, Duvillard P, Morice P (2009) Feasibility of ovarian cryopreservation in borderline ovarian tumours. Hum Reprod 24:850–855PubMedCrossRef Fain-Kahn V, Poirot C, Uzan C, Prades M, Gouy S, Genestie C, Duvillard P, Morice P (2009) Feasibility of ovarian cryopreservation in borderline ovarian tumours. Hum Reprod 24:850–855PubMedCrossRef
39.
go back to reference Walshe JM, Denduluri N, Swain S (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769–5779PubMedCrossRef Walshe JM, Denduluri N, Swain S (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769–5779PubMedCrossRef
40.
go back to reference Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin’s Lymphoma Study Group (2005) Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 23:7555–7564PubMedCrossRef Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin’s Lymphoma Study Group (2005) Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 23:7555–7564PubMedCrossRef
Metadata
Title
Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
Authors
Michael von Wolff
Markus Montag
Ralf Dittrich
Dominik Denschlag
Frank Nawroth
Barbara Lawrenz
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 2/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-1874-1

Other articles of this Issue 2/2011

Archives of Gynecology and Obstetrics 2/2011 Go to the issue